Plain-English translation of NCT06100991 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study—think of it as a careful tracking system for patients with generalized pustular psoriasis (GPP), a serious skin condition. Researchers will collect information about your disease, the treatments you receive, how well they work, and any side effects you experience. This helps doctors and scientists understand GPP better and learn which treatments are most helpful.
Generalized pustular psoriasis is rare and serious, and doctors need more real-world information about how patients actually respond to different treatments over time. This study helps fill that gap by collecting data that can improve care and guide future treatment decisions.
You likely qualify if…
You likely don't qualify if…
You would visit participating dermatology clinics and share your medical history, current treatments, and how your skin disease is affecting you. Researchers will collect information about your disease activity, any other health conditions you develop, medications you take, and how well treatments work. This is an ongoing registry, so you may be asked to provide updates about your health over time through visits or contact with the research team.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States
Enrollment target
~200 participants
Started
September 2023
Primary completion
December 2099
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Cathy Cheney
CorEvitas
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.